German Regulator’s Ties to BioNTech Under Scrutiny Amid COVID Vaccine Toxicity Questions

German Regulator’s Ties to BioNTech Under Scrutiny Amid COVID Vaccine Toxicity Questions Given the economic significance of BioNTech’s success for the German economy, allowing a German regulator — the Paul Ehrlich Institute — to approve Pfizer-BioNTech’s COVID-19 vaccine for all European Union member states raises conflict of interest questions. By    Brownstone Institute   Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. …Source

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes